HNSCC tumor progression is promoted by IL-8 via various mechanisms, such as the activation of MAPK/NF-κB and NOD1/RIP2 pathways and the reduction of JNK [46,47]. This evidence concerns the gene CXCL8 and head and neck squamous cell carcinoma.